Cancer Research Meeting Focuses on Range of Issues

Saying they were not asking for a lot of money compared to what is being spent in just a few days in the war in Kosovo, officials of the American Association for Cancer Research (AACR) called on Congress this month to double the National Cancer Institute's budget to $5 billion for fiscal year 2000 and increase it 20 percent per year for the succeeding four years. Such a boost would increase the federal government's annual investment in cancer research to $10 billion in five years. The plea cam

Written byLarry Hand
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Saying they were not asking for a lot of money compared to what is being spent in just a few days in the war in Kosovo, officials of the American Association for Cancer Research (AACR) called on Congress this month to double the National Cancer Institute's budget to $5 billion for fiscal year 2000 and increase it 20 percent per year for the succeeding four years. Such a boost would increase the federal government's annual investment in cancer research to $10 billion in five years.

The plea came at the end of the AACR's annual meeting, April 10-14 in Philadelphia, at which new research findings were presented and public forums featured opportunities for members of the public to "ask the experts" about cancer research issues. AACR leaders briefed journalists on their quest for increased funding on the final day of the meeting.

"We have been caught in the baby boomer ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies